CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
CANbridge Pharmaceuticals Inc. has successfully passed all resolutions during its Annual General Meeting held on June 27, 2024, with overwhelming shareholder approval, as the resolutions received votes approaching or reaching 100% in favor. Key resolutions included the re-election of executive and non-executive directors, re-appointment of Ernst & Young as the company’s auditor, and the adoption of amended Share Option and RSU Schemes. The approvals indicate strong shareholder confidence in the company’s governance and strategic plans moving forward.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.
